chrisvoncsefalvay/vaers-outcomes huggingface dataset:
elevated heartrate; clammy in her feet; anxious; wheezing; allergic reaction; rash on chest/rash on cheeks; extremely hot and sweaty; face was completely numb; hard time breathing; increased heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty) and HYPOAESTHESIA (face was completely numb) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIPOTRIOL (CALCITRENE), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ALPRAZOLAM (XANAX) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate) and RASH (rash on chest/rash on cheeks). On 15-Feb-2021, the patient experienced WHEEZING (wheezing) and HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet) and ANXIETY (anxious). The patient was treated with LORAZEPAM at an unspecified dose and frequency and DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate), WHEEZING (wheezing), HYPERSENSITIVITY (allergic reaction) and RASH (rash on chest/rash on cheeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal. On an unknown date, Electrocardiogram: normal. On an unknown date, X-ray: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included steroids.   This case was linked to MOD-2021-012336 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: No specific follow-up information recorded.
42 days since first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (42 days since first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (42 days since first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (42 days since first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported by reporter.   Reporter did not allow further contact
Injection site pain, 7 days Fever, 3 days Sleep disorder, 2 month
Ineffectiveness of the vaccine to build antibodies to SARS-CoV-2igG (anti-spike) test completed post vaccine, this resulted in my need to remain isolated for the entire time, I'm still in my home, I go nowhere expect to the doctors or lab since COVID started because I have no protection. I would like to say there is very few to any treatment options for immunocompromised or patients taking immunosuppressants if they get COVID. The lack of available treatment and its availability is extremely scarce and unacceptable. I feel like it's a low priority for our government and the CDC. People like me are stuck at home.
Achy like someone  stepped on her; Redness at the injection site; Swelling at the injection site; Intense itching where the swelling is; Muscles felt achy; Heat/ felt feverish; This case was reported by a consumer via call center representative and described the occurrence of pain in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th January 2020, the patient received the 1st dose of Shingrix (intramuscular). In January 2020, less than a week after receiving Shingrix, the patient experienced pain, injection site erythema, injection site swelling, injection site itching, myalgia and feeling hot. The patient was treated with PARACETAMOL (TYLENOL). On an unknown date, the outcome of the pain was not recovered/not resolved and the outcome of the injection site erythema and injection site swelling were recovering/resolving and the outcome of the injection site itching was resolved with sequelae and the outcome of the myalgia and feeling hot were unknown.   It was unknown if the reporter considered the pain, injection site erythema, injection site swelling, injection site itching, myalgia and feeling hot to be related to Shingrix.  Additional details were reported as follows: The patient received 1st dose of Shingrix and felt feverish and achy like someone stepped on her. She had redness and swelling at the injection site, which she treated with a warm soaks. She also stated that she had intense itching where the swelling was on her arm. The itching was resolved but the redness and swelling were still there although they were improved. The patient still felt like someone stepped on her at time of reporting and took Tylenol to relieve the symptoms. She also stated that her muscles felt achy. The reporter consented to follow up.
pt recv vax & began to hurt w/throbbing into muscle & down to elbow w/redness occurring from inj site to elbow;told to apply warm compress & notify MD if persists;
Patient received the meningococcal vaccine and was discharged from clinic. Within one minute after leaving room patient bump her on the wall and fell. Started to shake had her lay on her side about 5 minutes and then transferred her back to the room. Where she was kept in observation for 15 minutes. First fainting spell after vaccine.
Extreme vertigo and violent vomiting. Diagnosed as vestibular neuritis. Hospitalized three days. Found a herpes outbreak which indicated the cause of the virus. Two weeks of medications - Aciclovir, Meticorten, Vontrol, Diazepam (only while hospitalized). Diagnosis of months of recovery ahead.
Vaccination failure; COVID-19; Dose 1&2 pfizer; Moderna Dose 3; Pfizer Dose 4; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 4 (booster), single (Lot number: GJ5342) at the age of 49 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: EN6204), in left arm and on 14Apr2021 as dose 2, single (Lot number: ER8734), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 18Nov2021 as dose 3 (booster), single (Lot number: 046C21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Enlarged liver" (unspecified if ongoing); "hiatal hernia" (unspecified if ongoing). Concomitant medication(s) included: B19 [CYANOCOBALAMIN;PYRIDOXINE HYDROCHLORIDE;THIAMINE HYDROCHLORIDE], start date: 26Jan2022. Past drug history included: Albuterol, reaction(s): "one reaction of tongue, lip swelling", notes: Albuterol - one reaction of tongue, lip swelling; Melatonin, reaction(s): "one reaction full body hives for week", notes: melatonin - one reaction full body hives for week. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 18Nov2021, outcome "unknown", described as "Dose 1&2 pfizer; Moderna Dose 3; Pfizer Dose 4"; COVID-19 (medically significant) with onset Mar2023, outcome "recovering"; VACCINATION FAILURE (medically significant) with onset Mar2023, outcome "recovering". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included treatment with Paxlovid from 12Mar2023.   Clinical course: Covid symptoms mostly suppressed.
she feels like she is having a respiratory tract infection; Diarrhea; pain in the arm; a very bad headache; body pain; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation:Solution for injection, Lot number: not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient stated the side effects she experienced after the administration of the second dose of the Pfizer's COVID-19 vaccine. She felt like she was having pain in the arm, a very bad headache and body pain on an unspecified date in on Mar2021. She experienced a respiratory tract infection and diarrhea on 29Mar2021. Tylenol was given for the management of the symptoms. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
My period came two weeks early, the day after I got the second Pfizer dose. The bleeding was heavier and darker than usual. Today, September 1, 2021, I'm bleeding again and my period is not due until September 19.
Left thumb tremors--several over the course of a couple of days; pins and needles feeling in right foot-moved up leg to knee--daily for about two weeks; felt shaky inside my body, like my insides were turning around-happened daily for about a week, then five to six times times over the next two weeks, waking me up on two occasions, both early morning; dizziness and unsteadiness, shaky hands and all over for about three weeks. Have not had any of these symptoms since mid-March.  Reported to doctor by phone, as had just been in for physical and sinus infection follow up on February 12.
Lump on my left arm where my shot was given; it is hurting very bad and it got bigger; Lump on my left arm where my shot was given; it is hurting very bad and it got bigger; Nausea; Dizziness; Fever blisters around lips; Fever blisters around lips; Lymph node was inflamed; headaches; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on an unspecified date in 2021 as dose 1, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified dates in 2021, within one week of the vaccination, the patient experienced lump on left arm where shot was given; it was hurting very bad and it got bigger, and also experienced nausea, dizziness, fever blisters around lips, lymph node was inflamed and headaches. Patient didn't get any side effects other than nausea, dizziness and headaches for the first two days. But after a week, precise to a week the following Monday (unspecified date in 2021), patient experienced some sort of fever blisters around my lips and then following day, patient noticed, patient don't know when it started, underneath patient armpits where the shot was given. It's been almost two weeks and it has got a larger and larger and it hurts. Patient went through the center care yesterday (unspecified date) and they said there is a lymph node that was inflamed and also they gave some medication (for unspecified reason on unspecified date). That's just not the one, they said that's the largest one. Also, the ones on patients neck from left side, also got inflamed. Patient got the first shot vaccine around almost 3 weeks, tomorrow (at the time of report) would be 3 weeks ago, tomorrow patient was going for second shot. Patient don't know why it was a delayed reaction, patient don't know it has been persisting since the first week. Patient job was asking questions because they can't find a proof of side effects occurring after a week. Is it normal to have side effects after week. Patient believe events are related to the COVID vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Prior to vaccine administration pt told her mother she was nervous. Pt's mother stated that approximately one minute after vaccine administration pt began having difficulty breathing. Reaction nurse transported pt back to Med Obs 1 and med obs one gave graham crackers, water and assessed vitals 2x times. Both V/S presented normal. Pt was released at 1609 with last set of VS being time: 1606 hrs, P: 88, R: 18, BP: 114/70, SpO2: 99.
Her left hand start itching/right arm, then feet/itching moved all over her body, 18inch by 18inch patch on back, butt, legs.; Felt like they were on fire; Hives on steroids; Broke out in a whole body rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Her left hand start itching/right arm, then feet/itching moved all over her body, 18inch by 18inch patch on back, butt, legs.), FEELING ABNORMAL (Felt like they were on fire), URTICARIA (Hives on steroids) and RASH (Broke out in a whole body rash) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 025B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included THYROID (ARMOUR THYROID) for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced PRURITUS (Her left hand start itching/right arm, then feet/itching moved all over her body, 18inch by 18inch patch on back, butt, legs.), FEELING ABNORMAL (Felt like they were on fire), URTICARIA (Hives on steroids) and RASH (Broke out in a whole body rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency; CORTISONE ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and Manual therapy (Tried using an ice pack) for Rash. At the time of the report, PRURITUS (Her left hand start itching/right arm, then feet/itching moved all over her body, 18inch by 18inch patch on back, butt, legs.), FEELING ABNORMAL (Felt like they were on fire), URTICARIA (Hives on steroids) and RASH (Broke out in a whole body rash) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the patient started experiencing the adverse events in mid-August.   Patient went to the doctor and she told her to take Benadryl which she took and she reports it helped her get to sleep. The ice pack used by the patient worked the best but the cortisone cream  did not work. Benadryl helped the patient to get sleep.
hurt; This case was reported by a consumer and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingrix vaccine and felt a hurt. The follow-up would not possible as no contact details were available.
PATIENT WAS GIVEN THE PROQUAD AND A SEPERATE VARICELLA VACCINE TOGETHER ON DATE 06/17/19 HE HAS HAD NO REACTION TO THE VACCINES AT THIS DATE. THE VACCINATION WAS GIVEN BY, CCMA BY MISTAKE. PARENT HAS BEEN NOTIFIED OF THIS ACCIDENT.
Swelling in both lower legs and severe rash and itching. Lasted for 2 days. Still experiencing some form of it on day 3. But swelling has subsided and rash is healing.'
Sore arm for 2 days starting 1 day after injection. High fever 103+, Lingering headache, and general aches like the flu starting 5 days after injection. Fever continues for 3 days and maybe longer as of this report.
ITCHING AT SITE OF INJECTION RIGHT DELTOID WITH SOME ERYTHEMA AND ITCHING PROGRESSING TO RIGHT NECK ARM AND BACK. NO WHEEZING OR SOB.
No additional AE; Product was administered to patient after an excursion; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not provided.       On 29-NOV-2021 the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine Live recombinant human albumin (rHA)(PROQUAD) (lot # U015479 expiration date reported 13-NOV-2022) after an excursion for prophylaxis (product storage error).   The temperature of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored had been between 14F to 46F (31.8F) for 5 hours 30 minutes for lot U015479. There was previous temperature excursion. No additional adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2112USA001242:
Sudden hearing loss occurred causing muffled hearing in right ear.   (1) First had ear wax removed at urgent care (2) PCP prescribed prednisone with no success - 10 mg for 7 days  (3) After confirming audiological exam, ENT administered inner ear shots of prednisone over at 3/4 day intervals over 3 weeks with no success.  (4)  met with audiologist for hearing aid selection and hearing consult
Peak fevers of 104-105 and still continuing after 24hours that vaccine was given.  Leg where shot was given was stiff and did not want to move it or touch it until 24 hours later.
This case was reported by a other health professional via call center representative and described the occurrence of rash in a patient who received FLUARIX. In August 2011, the patient received FLUARIX. On an unknown date, unknown after receiving FLUARIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to FLUARIX. Additional details were reported as follows: The age at vaccination was not reported. The patient ?returned to primary care physician (PCP), and told the healthcare professional (HCP) that, the patient had a rash. No other information was provided by the HCP. The HCP did not want to provide further details.
This spontaneous report was received from a registered nurse and refers to a patient of unknown and gender. On an unknown date the patient was vaccinated with PNEUMOVAX23 (injection, lot # J006921 expiry date 09-AUG-2014; dose 0.5 ml, frequency unknown). The registered nurse reported that a under filled PNEUMOVAX23 vial caused an anonymous patient to miss a dose. No adverse events were reported. PQC was filled. It was not specified by the reporter if the therapy was discontinued. The outcome of the event was unknown. Additional information has been requested.
This spontaneous report was received from a registered nurse regarding an unspecified patients of unknown age and genders. The patients' medical history or conditions were not provided. The primary reporter stated that the patients were vaccinated with improperly stored doses of PNEUMOVAX23 (lot # L019836, expiration date 24-MAR-2017, dose, route of administration and anatomical location were not provided) possibly administered since approximately 06-APR-2016. Concomitant medications were not provided. There were no adverse effects reported. Temperature and time were reported as 0 degrees C for 160 hours. Previous temperature excursion was reported as 9C for 10 hours and 30 minutes. This is one of several reports from the same source (MARRS # 1604US0178128, 1604USA017912 and 1604USA017913). Additional information has been requested.
This case involves Adult and unknown gender patient who haven't had the flu since about '74 while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. In 1970, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number; formulation: not reported) via unknown route in unknown administration site for flu (prophylactic vaccination). On an unknown date the patient developed a non-serious event "haven't had the flu since about '74" (influenza) (unknown latency). It was reported "I never had the flu till I got my first flu shot in 1970. Had it each year for the next 3 or 4 years. Have never had another flu shot. Haven't had the flu since about '74." Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the event (Haven't had the flu since about '74). At time of reporting, the outcome was Unknown for the event haven't had the flu since about '74.
there was no excrusion from freezer; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (there was no excrusion from freezer) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (there was no excrusion from freezer). On 01-Oct-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (there was no excrusion from freezer) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant Medications details were provided. No treatment Medications details were provided.
Right arm  and Right palm of hand felt  dull sensation of numbness for  about 11 consecutive days. No treatment. Symptom(s) began to decrease one day after 11th day.
Patient came to clinic to receive 2nd dose of COVID vaccine. Pt presented with vaccination card that read patient had received Moderna vaccine. Pt received 2nd dose Moderna vaccine. Pt present to clinic approximately 20 min later presenting with another vaccine card that stated her first dose was Pfizer. Pts records reviewed in GRITS. Pts first dose received was Pfizer, second dose was Moderna. Pt received updated vaccination card and educated on incident.
Had MMR & VARIVAX injections 8/24/10. At site of VARIVAX injection approximately 7x9cm area of redness, tender. At site of MMR injection approximately 4x6cm area of redness, tender.
Pain in right gluteal region started 7/15/18. Worsened Mon 7/16 but patient was able to complete her run. Today (7/17) pain has worsened further, patient had to stop run because of pain. Ibuprofen has helped.